Laminar Pharma
is a Private company. Laminar Pharma has raised a total of $6.5M in funding. Laminar Pharma has 1 followers on Owler. Laminar Pharma has an estimated revenue of <$1M and an estimate of less <10 employees.Laminar Pharma
is a Private company. Laminar Pharma has raised a total of $6.5M in funding. Laminar Pharma has 1 followers on Owler. Laminar Pharma has an estimated revenue of <$1M and an estimate of less <10 employees.
CEO
Add
News
Feb 25, 2026
Benzinga
Laminar Pharma: Laminar Therapeutics Stock Is Popping Today: What's Going On?
Mar 06, 2025
Life Care News
Laminar Pharma: Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients
Nov 13, 2024
Born2Invest
Laminar Pharma: Laminar Pharma Raises 5.9 Million in a New Round of Financing
Jun 12, 2024
Clinical Trials Arena
Laminar Pharma: Laminar Pharmaceuticals finishes enrolling subjects in glioblastoma treatment trial
Apr 30, 2024
Born2Invest
Laminar Pharma: Laminar Pharma, Looking for Buyers in Europe for its New Anti-Tumor Drug
Mar 07, 2024
Life Care News
Laminar Pharma: Laminar Pharmaceuticals S.A. receives recommendation from the Independent Data Monitoring Committee to advance to the next stage of CLINGLIO, the phase 2b/3 Clinical Trial of LAM561 in combination with RT and TMZ for adults with newly diagnosed glioblastoma
May 31, 2023
Born2Invest
Laminar Pharma: Laminar Pharma Opens a 5 Million Round through Capital Cell
Apr 18, 2023
Born2Invest
Laminar Pharma: Laminar Pharma Expects to Reach 1 Billion in 2026 and Rules Out IPO